A 1-year, randomized, double-blind safety study of long-term treatment of a new gel formulation containing calcipotriene plus betamethasone dipropionate in scalp psoriasis

被引：0
|
作者：
Luger, Thomas [1 ]
Kidson, Paul [2 ]
Cambazard, Francois [3 ]
Larsen, Frederik Gronhoj [4 ]
机构：
[1] Univ Clin Munster, Munster, Germany
[2] LEO Pharma inc, Thornhill, ON, Canada
[3] CHU ST Etiene, Hop Nord, St Etienne, France
[4] Dermatol Practice, Frederiksberg, Denmark
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2008年 / 58卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：AB134 / AB134
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety results from a randomized, double-blind, vehicle-controlled study of clobetasol propionate spray for the treatment of moderate to severe plaque psoriasis of the scalp
    Cook-Bolden, Fran E.
    Goffe, Bernard S.
    Hudson, Charles P.
    Sofen, Howard L.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (03) : AB140 - AB140
  • [42] Long-term efficacy and safety of itolizumab in patients with moderate-to-severe chronic plaque psoriasis: A double-blind, randomized-withdrawal, placebo-controlled study
    Dogra, Sunil
    Krupashankar
    Budamakuntla, Leelavathy
    Srinivas, C. R.
    Khopkar, Uday
    Gupta, Sandesh
    Shetty, Narendra
    Pratap, Dasiga Venkata Subrahmanya
    Gopal, M. G.
    Rao, T. Narayana
    Garg, Vijay
    Sumathy, T. K.
    Saraswat, Abir
    Bhat, Ramesh
    Kura, Mahendra
    Pandey, Neeraj
    Shah, Radha
    Krishna, Kotla Sai
    Padmaja, Dalavai
    Manmohan, G.
    Ramakrishnan, M. S.
    Barve, Abhijit
    Montero, Enrique
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 73 (02) : 331 - 333
  • [43] The Long-Term Efficacy of Hydrocele Treatment with Aspiration and Sclerotherapy with Polidocanol Compared to Placebo: a Prospective, Double-Blind, Randomized Study
    Lund, L.
    Kloster, A.
    Cao, T.
    JOURNAL OF UROLOGY, 2014, 191 (05): : 1347 - 1350
  • [44] Efficacy and safety of idebenone in the long-term treatment of Alzheimer's disease: A double-blind, placebo controlled multicentre study
    Weyer, G
    Erzigkeit, H
    Hadler, D
    Kubicki, S
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 1996, 11 (01) : 53 - 65
  • [45] Long-term safety of twice-daily aclidinium bromide in COPD patients: A one-year, double-blind study
    Gelb, Arthur
    Tashkin, Donald
    Make, Barry
    Zhong, Xiaoyun
    Gil, Esther Garcia
    Caracta, Cynthia
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [46] Long-term Efficacy and Safety of Inebilizumab for Neuromyelitis Optica Spectrum Disorder in the Randomized, Double-blind N-MOmentum Study and Extension
    Cree, B. A. C.
    Bennett, J. L.
    Kim, H. J.
    Weinshenker, B.
    Pittock, S.
    Wingerchuk, D.
    Fujihara, K.
    Paul, F.
    Cutter, G.
    Marignier, R.
    Green, A.
    Aktas, O.
    Hartung, H-P.
    Lublin, F.
    Mealy, M. A.
    Drappa, J.
    Barron, G.
    Madani, S.
    She, D.
    Cimbora, D.
    Rees, W.
    Ratchford, J. N.
    Katz, E.
    NEUROLOGY, 2020, 94 (15)
  • [47] Long-term safety and tolerability of ezetimibe coadministered with simvastatin in hypercholesterolemic patients: a randomized, 12-month double-blind extension study
    Strony, John
    Yang, Bo
    Hanson, Mary E.
    Veltri, Enrico P.
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (11) : 3149 - 3157
  • [48] Safety of amisulpride vs risperidone in the long-term treatment of chronic schizophrenia: Results from a 12 month double-blind study
    Rein, W
    Fleurot, O
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S309 - S310
  • [49] Safety of long-term proactive management with fixed-dose combination calcipotriene 0.005% and betamethasone dipropionate 0.064% foam in patients with psoriasis vulgaris: Results of a phase III, multicenter, randomized, 52-week, vehicle-controlled trial
    Lebwohl, Mark
    Lacour, Jean Philippe
    Liljedahl, Monika
    Lynde, Charles
    Morch, Marie
    Snel-Prento, Anja
    Thaci, Diamant
    Warren, Richard B.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB1 - AB1
  • [50] Secukinumab for Long-Term Treatment of Psoriatic Arthritis: A Two-Year Followup From a Phase III, Randomized, Double-Blind Placebo-Controlled Study
    Kavanaugh, Arthur
    Mease, Philip J.
    Reimold, Andreas M.
    Tahir, Hasan
    Rech, Juergen
    Hall, Stephen
    Geusens, Piet
    Wang, Zailong
    Pricop, Luminita
    Mpofu, Shephard
    ARTHRITIS CARE & RESEARCH, 2017, 69 (03) : 347 - 355
12345